Coloplast AS (LTS:0QBO)
kr 891.7 -12.6 (-1.39%) Market Cap: 200.95 Bil Enterprise Value: 222.80 Bil PE Ratio: 39.90 PB Ratio: 11.26 GF Score: 92/100

Coloplast A/S at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 12:20PM GMT
Release Date Price: kr1098.5 (+2.11%)
Sebastian Walker
UBS Investment Bank, Research Division - Associate Analyst

Good morning or afternoon, everybody. Thank you for joining us today at the UBS Virtual Healthcare Conference. My name is Sebastian Walker. I run the European medtech team here in London. But more importantly, we've got Ellen Bjurgert, the Head of Investor Relations at Coloplast, who's joining us today for a presentation. Thanks very much for joining us.

So just for the format for everybody on the line. So Ellen is going to give an overview of the company and kind of key discussions for the first 30 minutes. So that will leave us some time for Q&A at the end of the presentation. So if you do have any questions that you'd like to ask, you should have access to a Q&A link in the schedule. But if you don't or if you prefer me to ask on your behalf, then feel free to send an e-mail to [email protected], and I can do that for you.

But with that, I'll hand it over to Ellen.

Ellen Bjurgert;S;VP of IR
Coloplast A

/-

Thank you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot